Non-Invasive Cancer Diagnostics Market Report

China Non-Invasive Cancer Diagnostics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 29, 2023
  • PAGES：235
  • REPORT CODE：GMM1818461
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market.

    The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment.

    This report elaborates on the current development of the Non-Invasive Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Laboratory Corporation of America Holdings (LabCorp)

    • Gen-Probe Inc

    • Affymetrix Inc

    • Precision Therapeutics

    • BIOVIEW Inc

    • Digene Corporation

    • AVIVA Biosciences Corporation

    • A&G Pharmaceutical

    • Cancer, Genetics Inc

    By Type:

    • Exosomes

    • CTNAS

    • CTCs

    By Application:

    • Blood

    • Urine

    • Saliva

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Non-Invasive Cancer Diagnostics Market Overview 2018-2029

    • 1.1 China Non-Invasive Cancer Diagnostics Industry Development Overview

    • 1.2 China Non-Invasive Cancer Diagnostics Industry Development History

    • 1.3 China Non-Invasive Cancer Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Non-Invasive Cancer Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Exosomes (2018-2029)

      • 1.4.2 China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of CTNAS (2018-2029)

      • 1.4.3 China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of CTCs (2018-2029)

    • 1.5 China Non-Invasive Cancer Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Blood (2018-2029)

      • 1.5.2 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Urine (2018-2029)

      • 1.5.3 China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Saliva (2018-2029)

    • 1.6 China Non-Invasive Cancer Diagnostics Market Analysis by Region

      • 1.6.1 North China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Non-Invasive Cancer Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Non-Invasive Cancer Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Non-Invasive Cancer Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Non-Invasive Cancer Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Non-Invasive Cancer Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Non-Invasive Cancer Diagnostics Industry Development

    Chapter 3 Non-Invasive Cancer DiagnosticsIndustry Chain Analysis

    • 3.1 Non-Invasive Cancer Diagnostics Industry Chain

    • 3.2 Non-Invasive Cancer Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Non-Invasive Cancer Diagnostics Market

    • 3.3 Non-Invasive Cancer Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Non-Invasive Cancer Diagnostics Market

    Chapter 4 China Non-Invasive Cancer Diagnostics Market, by Type

    • 4.1 China Non-Invasive Cancer Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Non-Invasive Cancer Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of Exosomes

      • 4.5.2 China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of CTNAS

      • 4.5.3 China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of CTCs

    Chapter 5 China Non-Invasive Cancer Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Non-Invasive Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Non-Invasive Cancer Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Blood

      • 5.5.2 China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Urine

      • 5.5.3 China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Saliva

    Chapter 6 China Non-Invasive Cancer Diagnostics Market, by Region

    • 6.1 China Non-Invasive Cancer Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Non-Invasive Cancer Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Non-Invasive Cancer Diagnostics Market Analysis

    • 7.1 North China Non-Invasive Cancer Diagnostics Market, by Type

    • 7.2 North China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 8 Central China Non-Invasive Cancer Diagnostics Market Analysis

    • 8.1 Central China Non-Invasive Cancer Diagnostics Market, by Type

    • 8.2 Central China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 9 South China Non-Invasive Cancer Diagnostics Market Analysis

    • 9.1 South China Non-Invasive Cancer Diagnostics Market, by Type

    • 9.2 South China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 10 East China Non-Invasive Cancer Diagnostics Market Analysis

    • 10.1 East China Non-Invasive Cancer Diagnostics Market, by Type

    • 10.2 East China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 11 Northeast China Non-Invasive Cancer Diagnostics Market Analysis

    • 11.1 Northeast China Non-Invasive Cancer Diagnostics Market, by Type

    • 11.2 Northeast China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 12 Southwest China Non-Invasive Cancer Diagnostics Market Analysis

    • 12.1 Southwest China Non-Invasive Cancer Diagnostics Market, by Type

    • 12.2 Southwest China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 13 Northwest China Non-Invasive Cancer Diagnostics Market Analysis

    • 13.1 Northwest China Non-Invasive Cancer Diagnostics Market, by Type

    • 13.2 Northwest China Non-Invasive Cancer Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Laboratory Corporation of America Holdings (LabCorp)

        • 14.1.1 Laboratory Corporation of America Holdings (LabCorp) Company Profile

        • 14.1.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Gen-Probe Inc

        • 14.2.1 Gen-Probe Inc Company Profile

        • 14.2.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Affymetrix Inc

        • 14.3.1 Affymetrix Inc Company Profile

        • 14.3.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Precision Therapeutics

        • 14.4.1 Precision Therapeutics Company Profile

        • 14.4.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 BIOVIEW Inc

        • 14.5.1 BIOVIEW Inc Company Profile

        • 14.5.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Digene Corporation

        • 14.6.1 Digene Corporation Company Profile

        • 14.6.2 Digene Corporation Non-Invasive Cancer Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AVIVA Biosciences Corporation

        • 14.7.1 AVIVA Biosciences Corporation Company Profile

        • 14.7.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 A&G Pharmaceutical

        • 14.8.1 A&G Pharmaceutical Company Profile

        • 14.8.2 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Cancer, Genetics Inc

        • 14.9.1 Cancer, Genetics Inc Company Profile

        • 14.9.2 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Non-Invasive Cancer Diagnostics Industry Research Conclusions

    • 15.2 Non-Invasive Cancer Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Non-Invasive Cancer Diagnostics Industry Market Size (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Exosomes (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of CTNAS (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of CTCs (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Blood (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Urine (2018-2029)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Saliva (2018-2029)

    • Figure North China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Non-Invasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Non-Invasive Cancer Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Non-Invasive Cancer Diagnostics Market Share by Type in 2018

    • Figure China Non-Invasive Cancer Diagnostics Market Share by Type in 2023

    • Figure China Non-Invasive Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of Exosomes (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of CTNAS (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume and Growth Rate of CTCs (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Market Share by Application in 2018

    • Figure China Non-Invasive Cancer Diagnostics Market Share by Application in 2023

    • Figure China Non-Invasive Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Blood (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Urine (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Market Size and Growth Rate of Saliva (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Production Volume by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Production Value by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Sales Value by Region (2018-2023)

    • Table China Non-Invasive Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Non-Invasive Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table North China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table South China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table East China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Non-Invasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Non-Invasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Non-Invasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Non-Invasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Laboratory Corporation of America Holdings (LabCorp) Company Profile

    • Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Gen-Probe Inc Company Profile

    • Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Affymetrix Inc Company Profile

    • Table Affymetrix Inc Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Precision Therapeutics Company Profile

    • Table Precision Therapeutics Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table BIOVIEW Inc Company Profile

    • Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Digene Corporation Company Profile

    • Table Digene Corporation Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table AVIVA Biosciences Corporation Company Profile

    • Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table A&G Pharmaceutical Company Profile

    • Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Cancer, Genetics Inc Company Profile

    • Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US